Title Credit Type Event date Costsort descending
Immunopathology: Evaluation from Discovery to Safety Assessment
    • 1.00 Participation
Enduring $35.00
TDAR assessments
    • 1.00 Participation
Enduring $35.00
Nonclinical Development of Biologics
    • 1.00 Participation
Enduring $35.00
CAR Therapy
    • 1.00 Participation
Enduring $35.00
Cytokine Release Syndrome (CRS)
    • 1.00 Participation
Enduring $35.00
CD3-binding (T cell engaging) immune stimulating antibody-based therapies
    • 1.00 Participation
Enduring $35.00
Gene Therapy
    • 1.00 Participation
Enduring $35.00
Immunophenotyping
    • 1.00 Participation
Enduring $35.00
Safety Considerations for Oligonucleotides
    • 1.00 Participation
Enduring $35.00
An Introduction to Immuno-Safety Science
    • 9.00 Participation
Enduring $350.00

Pages